FT-1518
Product Specifications
UNSPSC Description
FT-1518 is a new generation selective, potent and oral bioavailable mTORC1 and mTORC2 inhibitor, and exhibits antitumor activity.
Target Antigen
mTOR
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/FT-1518.html
Purity
98.14
Solubility
DMSO : 5 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
CCC(N1C2=NC(N3CC4OC(CC4)C3)=NC(C5=NC=C(N)N=C5)=C2N=C1)CC
Molecular Weight
394.47
References & Citations
[1]Alain C. Mita, et al. Abstract 137: FT-1518, a new generation selective and potent mTORC1 and mTORC2 inhibitor: an in vitro and in vivo profile. Cancer Res 2017;77(13 Suppl).
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-107363/FT-1518-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-107363/FT-1518-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1313026-58-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2136932-01 0.1 mL
PE Linked Polyclonal Antibody to Leukocyte Cell Derived Chemotaxin 2 (LECT2)
Ask
View Details MBS2136932-02 0.2 mL
PE Linked Polyclonal Antibody to Leukocyte Cell Derived Chemotaxin 2 (LECT2)
Ask
View Details